Mesenchymal Cell News Volume 14.20 | May 24 2022

    0
    20







    2022-05-24 | MESCN 14.20


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.20 – 24 May, 2022
    TOP STORY

    Target Receptor Identification and Subsequent Treatment of Resected Brain Tumors with Encapsulated and Engineered Allogeneic Stem Cells

    Scientists established a foundation towards a clinical trial of hydrogel encapsulated bifunctional MSCs in primary and recurrent glioblastoma patients.
    [Nature Communications]

    Full ArticlePress Release
    Register for a recorded organoid panel discussion moderated by Dr. James Wells
    PUBLICATIONSRanked by the impact factor of the journal

    MARK2 Regulates Directed Cell Migration through Modulation of Myosin II Contractility and Focal Adhesion Organization

    Using osteosarcoma cells, the authors found that in addition to its known localizations on microtubules and the plasma membrane, MARK2 also associated with the actomyosin cytoskeleton and focal adhesions.
    [Current Biology]

    Abstract

    Lef1 Ablation Alleviates Cartilage Mineralization Following Posttraumatic Osteoarthritis Induction

    Researchers determined the link between inflammation and cartilage mineralization by targeting Sirtuin 1 and lymphoid enhancer binding factor 1 (LEF1), both reported to have contrasting effects on cartilage.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    An Injectable Gelatin/Sericin Hydrogel Loaded with Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Uterine Injury

    A methacrylate gelatin and methacrylate sericin hydrogel with human umbilical cord mesenchymal stem cells encapsulation was designed for facilitating endometrial regeneration and fertility restoration through in situ injection.
    [Bioengineering & Translational Medicine]

    Full Article

    Myoglobin Expression by Alternative Transcript in Different Mesenchymal Stem Cells Compartments

    MSCs were isolated from human placental membrane, mammary adipose tissue and dental pulp and subjected to RT-PCR, Western blotting and mass spectrometry to investigate the expression of myoglobin.
    [Stem Cell Research & Therapy]

    Full ArticleGraphical Abstract

    Establishment of Organoids from Human Epithelioid Sarcoma with the Air-Liquid Interface Organoid Cultures

    Organoids from the epithelioid sarcoma could be serially cultured and maintained in collagen type 1 gels for more than three passages. Developed orthotopic tumor xenografts were detected in the NSG mice.
    [Frontiers in Oncology]

    Full Article

    Transfer of MicroRNA-22-3p by M2 Macrophage-Derived Extracellular Vesicles Facilitates the Development of Ankylosing Spondylitis through the PER2-Mediated Wnt/β-Catenin Axis

    Investigators elucidated the mechanisms regarding extracellular vesicle-packaged microRNA-22-3p from M2 macrophages in the osteogenic differentiation of MSCs in ankylosing spondylitis.
    [Cell Death Discovery]

    Full Article

    Human Induced Mesenchymal Stem Cells Display Increased Sensitivity to Matrix Stiffness

    Scientists tested the mechanosensing properties of three human homogeneous MSC lines derived from induced pluripotent stem cells generated using a fully automated platform.
    [Scientific Reports]

    Full Article

    Effects of Interleukin 1β on Long Noncoding RNA and mRNA Expression Profiles of Human Synovial Fluid Derived Mesenchymal Stem Cells

    Investigators evaluated the long noncoding RNA and mRNA expression profiles of interleukin-1β-stimulated synovial fluid-derived MSCs.
    [Scientific Reports]

    Full Article

    Synergistic Effects of Fluid Shear Stress and Adhesion Morphology on the Apoptosis and Osteogenesis of Mesenchymal Stem Cells

    Researchers demonstrated the synergistic effects of fluid shear stress and adhesion morphology in directing the fate of MSCs, and these effects may be adopted to design bio-functional substrates for cell transplantation in tissue engineering.
    [Journal of Biomedical Materials Research Part A]

    Abstract

    SATB1 Promotes Osteogenic Differentiation of Diabetic Rat BMSCs through MAPK Signaling Activation

    Bone marrow-derived MSCs were collected from type 2 diabetes rat model and the protein and gene expression of special AT-Rich Binding protein 1 (SATB1), and osteospecific genes were evaluated post osteogenic induction.
    [Oral Diseases]

    Abstract

    Oral Delivery of Stem-Cell-Loaded Hydrogel Microcapsules Restores Gut Inflammation and Microbiota

    The oral delivery of stem-cell-loaded hydrogel microcapsules enhanced MSC survival and retention in the hostile stomach environment due to the intermediate oil layer and low value of the overall stiffness.
    [Journal of Controlled Release]

    AbstractGraphical Abstract

    The Microenvironment of Silk/Gelatin Nanofibrous Scaffold Improves Proliferation and Differentiation of Wharton’s Jelly-Derived Mesenchymal Cells into Islet-Like Cells

    Researchers investigated the differentiation of Wharton’s jelly-derived MSCs into pancreatic islet-insulin producing cells on silk/gelatin nanofibers as a 3D scaffold.
    [Gene]

    Abstract
    ON1012PSC-StemCellfie2021-BrowseTheGallery-728x90-1
    REVIEWS

    The Circadian Clock Has Roles in Mesenchymal Stem Cell Fate Decision

    Scientists focus on the close relationship between the circadian clock and MSC l fate decisions in the skeletal system.
    [Stem Cell Research & Therapy]

    Full Article

    The Deadly Cross-Talk between Hippo Pathway and Epithelial–Mesenchymal Transition (EMT) in Cancer

    The authors describe the existing evidence of cross talk between Hippo signaling pathway key molecules and the process of EMT, with emphasis on the role of Hippo—EMT interplay in cancer.
    [Molecular Biology Reports]

    Abstract
    INDUSTRY AND POLICY NEWS

    Calidi Biotherapeutics Granted US Patent for Proprietary Therapeutic Delivery Platform, Strengthening Company’s Intellectual Property Position in Immunotherapy

    Calidi Biotherapeutics, Inc. has been granted a new patent by the US Patent and Trademark Office related to its proprietary SuperNova (SNV) technology platform. The SNV platform is composed of allogeneic, adipose-derived MSCs loaded with an oncolytic agent.
    [Calidi Biotherapeutics, Inc.]

    Press Release
    FEATURED EVENT

    ISSCR 2022 Annual Meeting

    June 15 – 18, 2022
    San Francisco, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Bone Regeneration

    TU Dresden – Dresden, Germany

    Postdoctoral Research Fellow – Musculoskeletal Medicine

    University of Leeds – Leeds, United Kingdom

    Research Associate – Mesenchymal Progenitors

    The University of British Columbia – Vancouver, British Columbia, Canada

    Research Assistant – Effects of Chemical Exposure

    Wayne State University – Detroit, Michigan, United States

    Postdoctoral Associate – Planarian Stem Cell Biology and Regeneration

    Baylor College of Medicine – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter